跳至主要内容
临床试验/NCT06655025
NCT06655025已完成不适用

The Effects of Dexmedetomidine on Postoperative Cognitive Function and Neuron-Specific Enolase Levels in Open Heart Surgery

Sohag University1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2023年10月8日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Serum neuron-specific enolase levels

研究概览

简要总结

To assess the impact of Dexmedetomidine on postoperative cognitive function and serum Neuron Specific Enolase levels as an indicator of neuronal injury in patients undergoing open heart surgery

详细描述

This randomized controlled study was conducted to evaluate the effects of dexmedetomidine on postoperative cognitive function in patients undergoing elective open-heart surgery. Patients were randomly assigned into two groups: a dexmedetomidine group receiving intravenous dexmedetomidine infusion during surgery and a control group receiving normal saline infusion as placebo in addition to standard anesthesia.

Postoperative cognitive function was assessed using the Mini-Mental State Examination (MMSE). Serum neuron-specific enolase (NSE) levels were measured as a biomarker of neuronal injury. Intraoperative depth of anesthesia was monitored using the bispectral index (BIS). The aim of the study was to investigate whether dexmedetomidine administration could reduce postoperative cognitive dysfunction and neuronal injury in patients undergoing cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participants, investigators, and outcome assessors were blinded to group allocation. Dexmedetomidine and placebo solutions were prepared in identical syringes by an independent anesthesiologist not involved in patient management or data collection.

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients of both sexes undergoing elective open-heart surgery

排除标准

  • Patients with a history of neurological disorders, severe renal or liver dysfunction, or contraindications to Dexmedetomidine as in patients with known QT prolongation, a history of other arrhythmias, symptomatic bradycardia, hypokalemia, or hypomagnesemia, and in patients receiving other drugs known to prolong the QT interval.
  • Patients with cognitive impairment, mental and psychological illness and chronic alcoholics, drug addicts, abuse of psychotropic substances, illiterate education

研究组 & 干预措施

Group B (Dexmedetomidine)

Active Comparator

Patients receive intravenous dexmedetomidine infusion during open-heart surgery in addition to standard anesthesia.

干预措施: Dexmedetomidine (Drug)

Group A (control)

Placebo Comparator

Patients receive intravenous normal saline infusion during surgery as placebo control in addition to standard anesthesia.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Serum neuron-specific enolase levels

时间窗: Preoperative baseline and 12 hours after surgery

Serum neuron-specific enolase levels will be measured as a biomarker of neuronal injury.

Postoperative cognitive function

时间窗: Preoperative baseline, and at 1 day, 3 days, and 7 days after surgery

Cognitive function will be evaluated using the Mini-Mental State Examination (MMSE).

次要结局

  • Postoperative cognitive function(Preoperative baseline, and at 1 day, 3 days, and 7 days after surgery)
  • Serum neuron-specific enolase levels(Preoperative baseline and 12 hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Salaheldin Ahmed Abdelziz

specialist

Sohag University

研究点 (1)

Loading locations...

相似试验